CAS: 126453-07-4 - D-cpp
Fórmula:C8H17N2O5P
InChI:InChI=1S/C8H17N2O5P/c11-8(12)7-6-10(4-2-9-7)3-1-5-16(13,14)15/h7,9H,1-6H2,(H,11,12)(H2,13,14,15)/t7-/m1/s1
Clave InChI:InChIKey=CUVGUPIVTLGRGI-SSDOTTSWSA-N
SMILES:O=C(O)C1NCCN(CCCP(=O)(O)O)C1
- Sinónimos:
- (2R)-4-(3-Phosphonopropyl)-2-piperazinecarboxylic acid
- (2R)-4-(3-phosphonopropyl)piperazine-2-carboxylic acid
- (R)-Cpp
- 2-Piperazinecarboxylic acid, 4-(3-phosphonopropyl)-, (2R)-
- 2-Piperazinecarboxylic acid, 4-(3-phosphonopropyl)-, (R)-
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 2-Piperazinecarboxylic acid, 4-(3-phosphonopropyl)-, (2R)- REF: AN-AG000STACAS: 126453-07-4 | 95% | A consultar | Mar 28 May 24 |
 | (R)-CPP REF: 3D-BC168104CAS: 126453-07-4 | Min. 95% | 485,00 €~2.791,00 € | Mar 09 Jul 24 |
 | (R)-CPP REF: TM-T23222CAS: 126453-07-4 | 98% | 92,00 €~2.337,00 € | Mar 16 Jul 24 |
2-Piperazinecarboxylic acid, 4-(3-phosphonopropyl)-, (2R)-
CAS:126453-07-4
Fórmula:
C8H17N2O5P
Pureza:
95%
Forma y color:
Solid
Peso molecular:
252.2047
Ref: AN-AG000STA
| 1mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 28 de Mayo de 2024
(R)-CPP
CAS:126453-07-4
NMDA receptor antagonist
Fórmula:
C8H17N2O5P
Pureza:
Min. 95%
Peso molecular:
252.2 g/mol
Ref: 3D-BC168104
| 10mg | 485,00 € | |
| 25mg | 863,00 € | |
| 50mg | 1.467,00 € | |
| 100mg | 1.948,00 € | |
| 500mg | 2.791,00 € |
Entrega estimada en Estados Unidos, el Martes 9 de Julio de 2024
(R)-CPP
CAS:126453-07-4
(R)-CPP is a NMDA antagonist.
Fórmula:
C8H17N2O5P
Pureza:
98%
Forma y color:
Solid
Peso molecular:
252.2
Ref: TM-T23222
| 1mg | 92,00 € | |
| 5mg | 402,00 € | |
| 10mg | 757,00 € | |
| 25mg | 1.669,00 € |
Entrega estimada en Estados Unidos, el Martes 16 de Julio de 2024
